<Entities><Entity><Demographics><PatientName>Jack Sparrow</PatientName><PatientPhone>555-555-5555</PatientPhone><PatientEmail>555-555-5555</PatientEmail><DOB>09/18/1985</DOB><InsuranceProvider>Blue Cross Blue Shield of Oklahoma</InsuranceProvider><InsurancePolicy >YUP8357788</InsurancePolicy ><ReferringPhysician>Dr. Block</ReferringPhysician><ReferringPhysicianemail>block@block.com</ReferringPhysicianemail></Demographics><ClinicalData><ICD10s><Data><Description>Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene</Description><Code>E11.51</Code><Score>0.8875475525856018</Score></Data><Data><Description>Type 2 diabetes mellitus with diabetic nephropathy</Description><Code>E11.21</Code><Score>0.7889286875724792</Score></Data><Data><Description>Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene</Description><Code>E10.51</Code><Score>0.7600046992301941</Score></Data><Data><Description>Type 2 diabetes mellitus with other diabetic kidney complication</Description><Code>E11.29</Code><Score>0.7460819482803345</Score></Data></ICD10s><Medications><Data><Text>Levothyroxine</Text><DOSAGE>20 Milligrams</DOSAGE><ROUTE_OR_MODE>p.o.</ROUTE_OR_MODE><FREQUENCY>once daily</FREQUENCY></Data><Data><Text>Lisinipril</Text><DOSAGE>125 micrograms</DOSAGE><ROUTE_OR_MODE>p.o.</ROUTE_OR_MODE><FREQUENCY>once daily</FREQUENCY></Data></Medications><LabResults><Data><Type>PSA</Type><Result>4.2</Result><Date>10/01/2021</Date></Data><Data><Type>PSA</Type><Result>3.1</Result><Date>06/01/2021</Date></Data><Data><Type>Creatinine</Type><Result>0.7</Result><Date>9/01/2021</Date></Data><Data><Type>Creatinine</Type><Result>0.8</Result><Date>10/01/2021</Date></Data><Data><Type>Creatinine</Type><Result>1.1</Result><Date>11/01/2021</Date></Data></LabResults></ClinicalData></Entity></Entities>